Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea.

about

Clinical outcomes of everolimus in patients with advanced, nonfunctioning pancreatic neuroendocrine tumors: a multicenter study in Korea.

Item

http://www.wikidata.org/entity/Q50201468

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical outcomes of everolimu ...... a multicenter study in Korea.

@en

Clinical outcomes of everolimu ...... a multicenter study in Korea.

@nl

type

Item

label

Clinical outcomes of everolimu ...... a multicenter study in Korea.

@en

Clinical outcomes of everolimu ...... a multicenter study in Korea.

@nl

prefLabel

Clinical outcomes of everolimu ...... a multicenter study in Korea.

@en

Clinical outcomes of everolimu ...... a multicenter study in Korea.

@nl

P1476

Clinical outcomes of everolimu ...... : a multicenter study in Korea

@en

P2093

Jae Hee Cho

http://www.w3.org/2001/XMLSchema#string

Ji Kon Ryu

http://www.w3.org/2001/XMLSchema#string

Jong Kyun Lee

http://www.w3.org/2001/XMLSchema#string

Kwang Hyuk Lee

http://www.w3.org/2001/XMLSchema#string

Kyong Joo Lee

http://www.w3.org/2001/XMLSchema#string

Sang Hyub Lee

http://www.w3.org/2001/XMLSchema#string

Sang Myung Woo

http://www.w3.org/2001/XMLSchema#string

Seok Jeong

http://www.w3.org/2001/XMLSchema#string

Tae Hoon Lee

http://www.w3.org/2001/XMLSchema#string

Woo Hyun Paik

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Lanreotide in metastatic enteropancreatic neuroendocrine tumors

Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors

Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms.

Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas.

Real-world study of everolimus in advanced progressive neuroendocrine tumors.

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

Everolimus for advanced pancreatic neuroendocrine tumors.

Everolimus for advanced pancreatic neuroendocrine tumours: a subgroup analysis evaluating Japanese patients in the RADIANT-3 trial.

Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study.

P2888

s00280-017-3421-7

P304

799-805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-017-3421-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Seungmin Bang

Si Young Song

P577

2017-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28884280

http://www.w3.org/2001/XMLSchema#string